WAVE Life Sciences Ltd (WVE)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: WVE Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2024-04-05	2024-04-03	PS Planned sale	Moran Kyle Chief Financial Officer Officer	15,630 -31.5% 6.17 96,421 USD	15,630 -31.5%	6.17	96,421 USD
2023-12-13	2023-12-11	B Purchase	RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Major owner	1,000,000 +5.5% 5.00 5,000,000 USD	1,000,000 +5.5%	5.00	5,000,000 USD
2024-01-30	2023-12-07	B Purchase	GSK plc Major owner	3,300,000 +30.9% 5.00 16,500,000 USD	3,300,000 +30.9%	5.00	16,500,000 USD
2023-08-23	2023-08-23	PS Planned sale	Moran Kyle Chief Financial Officer Officer	37,062 -44.6% 4.75 176,119 USD	37,062 -44.6%	4.75	176,119 USD
2023-02-17	2023-02-16	S Sale	Vargeese Chandra See Remarks Officer	10,249 -8.8% 4.03 41,303 USD	10,249 -8.8%	4.03	41,303 USD
2023-02-17	2023-02-16	S Sale	Moran Kyle Chief Financial Officer Officer	9,729 -10.9% 4.04 39,305 USD	9,729 -10.9%	4.04	39,305 USD
2023-02-17	2023-02-16	S Sale	Francis Chris See Remarks Officer	10,258 -11.4% 4.03 41,340 USD	10,258 -11.4%	4.03	41,340 USD
2023-02-17	2023-02-16	S Sale	BOLNO PAUL President and CEO Executive Director	29,400 -6.7% 4.04 118,776 USD	29,400 -6.7%	4.04	118,776 USD
2022-06-21	2022-06-16	B Purchase	RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Major owner	9,480,052 +122.8% 2.15 20,382,112 USD	9,480,052 +122.8%	2.15	20,382,112 USD
2022-05-06	2022-05-05	PS Planned sale	BOLNO PAUL President and CEO Executive Director	33,501 -7.1% 1.72 57,622 USD	33,501 -7.1%	1.72	57,622 USD
2022-05-06	2022-05-05	PS Planned sale	Francis Chris See Remarks Officer	10,867 -10.8% 1.72 18,691 USD	10,867 -10.8%	1.72	18,691 USD
2022-05-06	2022-05-05	PS Planned sale	Vargeese Chandra See Remarks Officer	16,714 -13.1% 1.72 28,748 USD	16,714 -13.1%	1.72	28,748 USD
2022-05-06	2022-05-05	PS Planned sale	Moran Kyle Chief Financial Officer Officer	5,021 -5.6% 1.72 8,636 USD	5,021 -5.6%	1.72	8,636 USD
2022-05-06	2022-05-05	PS Planned sale	Panzara Michael A. See Remarks Officer	16,714 -13.3% 1.72 28,748 USD	16,714 -13.3%	1.72	28,748 USD
2022-02-18	2022-02-16	S Sale	Moran Kyle Chief Financial Officer Officer	9,204 -11.0% 2.31 21,261 USD	9,204 -11.0%	2.31	21,261 USD
2022-02-18	2022-02-16	S Sale	Francis Chris See Remarks Officer	10,123 -12.9% 2.31 23,384 USD	10,123 -12.9%	2.31	23,384 USD
2022-02-18	2022-02-16	S Sale	Panzara Michael A. See Remarks Officer	10,603 -12.3% 2.31 24,493 USD	10,603 -12.3%	2.31	24,493 USD
2022-02-18	2022-02-16	S Sale	BOLNO PAUL President and CEO Executive Director	33,150 -8.1% 2.32 76,908 USD	33,150 -8.1%	2.32	76,908 USD
2022-02-18	2022-02-16	S Sale	Vargeese Chandra Chief Technology Officer Officer	10,603 -12.0% 2.32 24,599 USD	10,603 -12.0%	2.32	24,599 USD
2021-02-18	2021-02-16	PS Planned sale	Moran Kyle Chief Financial Officer Officer	1,722 -2.4% 10.57 18,202 USD	1,722 -2.4%	10.57	18,202 USD
2021-02-18	2021-02-16	PS Planned sale	Francis Chris See Remarks Officer	2,698 -3.3% 10.57 28,518 USD	2,698 -3.3%	10.57	28,518 USD
2021-02-18	2021-02-16	PS Planned sale	Vargeese Chandra Chief Technology Officer Officer	3,145 -3.6% 10.57 33,243 USD	3,145 -3.6%	10.57	33,243 USD
2021-02-18	2021-02-16	PS Planned sale	BOLNO PAUL President and CEO Executive Director	11,205 -2.7% 10.57 118,437 USD	11,205 -2.7%	10.57	118,437 USD
2021-02-18	2021-02-16	PS Planned sale	Panzara Michael A. See Remarks Officer	2,929 -3.3% 10.57 30,960 USD	2,929 -3.3%	10.57	30,960 USD
2020-09-17	2020-09-15	PS Planned sale	BOLNO PAUL President and CEO Executive Director	100,000 -26.9% 15.00 1,500,000 USD	100,000 -26.9%	15.00	1,500,000 USD
2020-08-27	2020-08-25	PS Planned sale	BOLNO PAUL President and CEO Executive Director	25,000 -8.4% 12.00 300,000 USD	25,000 -8.4%	12.00	300,000 USD
2020-07-02	2020-07-02	PS Planned sale	BOLNO PAUL President and CEO Executive Director	95,921 -26.1% 10.27 985,109 USD	95,921 -26.1%	10.27	985,109 USD
2020-07-02	2020-07-02	PS Planned sale	BOLNO PAUL President and CEO Executive Director	4,079 -1.1% 10.91 44,502 USD	4,079 -1.1%	10.91	44,502 USD
2020-07-02	2020-07-02	PS Planned sale	BOLNO PAUL President and CEO Executive Director	43,068 -13.7% 10.26 441,878 USD	43,068 -13.7%	10.26	441,878 USD
2020-07-02	2020-07-02	PS Planned sale	BOLNO PAUL President and CEO Executive Director	4,509 -1.4% 10.82 48,787 USD	4,509 -1.4%	10.82	48,787 USD
2020-02-20	2020-02-18	PS Planned sale	Panzara Michael A. Chief Medical Officer Officer	2,981 -7.0% 7.85 23,401 USD	2,981 -7.0%	7.85	23,401 USD
2020-02-20	2020-02-18	PS Planned sale	BOLNO PAUL President and CEO Executive Director	11,451 -3.5% 7.85 89,890 USD	11,451 -3.5%	7.85	89,890 USD
2020-02-20	2020-02-18	PS Planned sale	Francis Chris See Remarks Officer	2,708 -8.0% 7.85 21,258 USD	2,708 -8.0%	7.85	21,258 USD
2020-02-20	2020-02-18	PS Planned sale	Vargeese Chandra Senior VP, Drug Discovery Officer	3,188 -7.9% 7.85 25,026 USD	3,188 -7.9%	7.85	25,026 USD
2020-02-05	2020-02-03	PS Planned sale	Gaiero David G Interim CFO	651 -9.2% 7.00 4,557 USD	651 -9.2%	7.00	4,557 USD
2019-12-05	2019-12-03	PS Planned sale	Vargeese Chandra Senior VP, Drug Discovery Officer	6,000 -13.0% 35.00 210,000 USD	6,000 -13.0%	35.00	210,000 USD
2019-11-22	2019-11-20	S Sale	Verdine Gregory L. Non-Executive Director	2,609 -8.0% 32.74 85,419 USD	2,609 -8.0%	32.74	85,419 USD
2019-11-22	2019-11-20	S Sale	Verdine Gregory L. Non-Executive Director	3,400 -9.4% 31.59 107,406 USD	3,400 -9.4%	31.59	107,406 USD
2019-11-22	2019-11-20	S Sale	Verdine Gregory L. Non-Executive Director	24,030 -40.0% 30.27 727,388 USD	24,030 -40.0%	30.27	727,388 USD
2019-07-09	2019-07-05	PS Planned sale	Panzara Michael A. Chief Medical Officer	445 -1.0% 27.26 12,131 USD	445 -1.0%	27.26	12,131 USD
2019-07-09	2019-07-05	PS Planned sale	Panzara Michael A. Chief Medical Officer	2,613 -5.8% 26.88 70,237 USD	2,613 -5.8%	26.88	70,237 USD
2019-03-19	2019-03-15	PS Planned sale	BOLNO PAUL President and CEO Executive Director	1,763 -0.5% 46.00 81,098 USD	1,763 -0.5%	46.00	81,098 USD
2019-03-19	2019-03-15	PS Planned sale	BOLNO PAUL President and CEO Executive Director	8,237 -2.4% 45.22 372,477 USD	8,237 -2.4%	45.22	372,477 USD
2019-03-19	2019-03-15	PS Planned sale	BOLNO PAUL President and CEO Executive Director	5,065 -1.5% 45.89 232,433 USD	5,065 -1.5%	45.89	232,433 USD
2019-03-19	2019-03-15	PS Planned sale	BOLNO PAUL President and CEO Executive Director	34,935 -9.2% 45.45 1,587,796 USD	34,935 -9.2%	45.45	1,587,796 USD
2019-03-11	2019-03-11	PS Planned sale	Panzara Michael A. Franchise Lead, Neurology	7,000 -13.4% 48.00 336,000 USD	7,000 -13.4%	48.00	336,000 USD
2019-02-21	2019-02-19	PS Planned sale	Panzara Michael A. Franchise Lead, Neurology Officer	1,837 -4.7% 36.84 67,674 USD	1,837 -4.7%	36.84	67,674 USD
2019-02-21	2019-02-19	PS Planned sale	Regnante Keith Chief Financial Officer Officer	1,298 -7.6% 36.84 47,818 USD	1,298 -7.6%	36.84	47,818 USD
2019-02-21	2019-02-19	PS Planned sale	Vargeese Chandra Senior VP, Drug Discovery Officer	2,055 -7.5% 36.84 75,706 USD	2,055 -7.5%	36.84	75,706 USD
2019-02-21	2019-02-19	PS Planned sale	Francis Chris See Remarks Officer	1,709 -7.7% 36.84 62,959 USD	1,709 -7.7%	36.84	62,959 USD
2019-02-21	2019-02-19	PS Planned sale	BOLNO PAUL President and CEO Executive Director	119 -0.0% 37.47 4,458 USD	119 -0.0%	37.47	4,458 USD
2019-02-21	2019-02-19	PS Planned sale	BOLNO PAUL President and CEO Executive Director	7,614 -2.7% 36.38 276,997 USD	7,614 -2.7%	36.38	276,997 USD
2019-01-28	2019-01-24	B Purchase	RA CAPITAL MANAGEMENT, LLC Non-Executive Director Major owner	263,158 +3.5% 38.00 10,000,004 USD	263,158 +3.5%	38.00	10,000,004 USD
2018-11-16	2018-11-14	S Sale	Verdine Gregory L. Non-Executive Director	4,300 -6.7% 39.52 169,936 USD	4,300 -6.7%	39.52	169,936 USD
2018-11-16	2018-11-14	S Sale	Verdine Gregory L. Non-Executive Director	10,700 -14.3% 38.59 412,913 USD	10,700 -14.3%	38.59	412,913 USD
2018-09-26	2018-09-25	PS Planned sale	Francis Chris See Remarks Officer	10,543 -32.3% 56.00 590,408 USD	10,543 -32.3%	56.00	590,408 USD
2018-09-26	2018-09-24	PS Planned sale	Vargeese Chandra Senior VP, Drug Discovery Officer	3,000 -9.9% 55.00 165,000 USD	3,000 -9.9%	55.00	165,000 USD
2018-09-26	2018-09-24	PS Planned sale	Regnante Keith Chief Financial Officer Officer	29,500 -63.5% 55.00 1,622,500 USD	29,500 -63.5%	55.00	1,622,500 USD
2018-09-26	2018-09-24	PS Planned sale	Francis Chris See Remarks Officer	1,032 -4.5% 56.00 57,792 USD	1,032 -4.5%	56.00	57,792 USD
2018-07-11	2018-07-09	PS Planned sale	Francis Chris See Remarks Officer	596 -2.6% 38.22 22,779 USD	596 -2.6%	38.22	22,779 USD
2018-07-11	2018-07-09	PS Planned sale	Francis Chris See Remarks Officer	23,900 -52.0% 37.25 890,275 USD	23,900 -52.0%	37.25	890,275 USD
2018-06-01	2018-06-01	PS Planned sale	Francis Chris See Remarks Officer	24,496 -52.6% 48.00 1,175,808 USD	24,496 -52.6%	48.00	1,175,808 USD
2018-06-01	2018-05-30	PS Planned sale	Francis Chris See Remarks Officer	24,496 -52.6% 45.50 1,114,568 USD	24,496 -52.6%	45.50	1,114,568 USD
2018-05-30	2018-05-30	PS Planned sale	BOLNO PAUL President and CEO Executive Director	20,250 -6.8% 45.00 911,250 USD	20,250 -6.8%	45.00	911,250 USD
2018-05-30	2018-05-29	PS Planned sale	BOLNO PAUL President and CEO Executive Director	3,145 -1.1% 45.00 141,525 USD	3,145 -1.1%	45.00	141,525 USD
2018-05-30	2018-05-25	PS Planned sale	BOLNO PAUL President and CEO Executive Director	8,316 -2.9% 45.00 374,220 USD	8,316 -2.9%	45.00	374,220 USD
2018-05-04	2018-05-02	PS Planned sale	BOLNO PAUL President and CEO Executive Director	18,289 -6.2% 45.00 823,005 USD	18,289 -6.2%	45.00	823,005 USD
2018-02-21	2018-02-20	PS Planned sale	Francis Chris See Remarks Officer	11,504 -34.3% 55.95 643,649 USD	11,504 -34.3%	55.95	643,649 USD
2018-02-21	2018-02-16	PS Planned sale	BOLNO PAUL President and CEO Executive Director	2,200 -0.8% 51.62 113,564 USD	2,200 -0.8%	51.62	113,564 USD
2018-02-21	2018-02-16	PS Planned sale	BOLNO PAUL President and CEO Executive Director	514 -0.2% 51.01 26,219 USD	514 -0.2%	51.01	26,219 USD
2018-02-21	2018-02-16	PS Planned sale	Panzara Michael A. Franchise Lead, Neurology Officer	511 -1.3% 52.10 26,623 USD	511 -1.3%	52.10	26,623 USD
2018-02-21	2018-02-16	PS Planned sale	Regnante Keith Chief Financial Officer Officer	316 -1.8% 51.85 16,385 USD	316 -1.8%	51.85	16,385 USD
2018-02-21	2018-02-16	PS Planned sale	Francis Chris See Remarks Officer	9,412 -29.9% 55.00 517,660 USD	9,412 -29.9%	55.00	517,660 USD
2018-02-21	2018-02-16	PS Planned sale	Francis Chris See Remarks Officer	723 -3.2% 51.80 37,451 USD	723 -3.2%	51.80	37,451 USD
2018-02-20	2018-02-15	PS Planned sale	Panzara Michael A. Franchise Lead, Neurology Officer	18,750 -32.1% 50.00 937,500 USD	18,750 -32.1%	50.00	937,500 USD